Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
Kristine Griffett, Thomas P. Burris
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19

Showing 19 citing articles:

A mutation in LXRα uncovers a role for cholesterol sensing in limiting metabolic dysfunction-associated steatohepatitis
Alexis T. Clark, Lillian Russo-Savage, Luke A. Ashton, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease
Milton Antwi, Ariann Jennings, Sander Lefere, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 6
Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways
Sultan Kadasah, Mohamed O. Radwan
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2845-2845
Open Access | Times Cited: 14
The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Zhenhua Yang, Awang Danzeng, Qiumeng Liu, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 113-126
Open Access | Times Cited: 14
Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients
Woonghee Kim, Mengzhen Li, Han Jin, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107727-107727
Open Access | Times Cited: 11
Mechanism of liver x receptor alpha in intestine, liver and adipose tissues in metabolic associated fatty liver disease
Kaiwen Lei, Runsheng Chen, Jian‐Xing Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 142275-142275
Closed Access
Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell Inflammation
Damien Leleu, Thomas Pilot, Léa Mangin, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2025)
Closed Access
Intestinal Activation of LXRα Counteracts Metabolic-Associated Steatohepatitis Features in Mice
Gessica Lioci, Fabio Gurrado, Nadia Panera, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1349-1349
Open Access
Harnessing Oleanolic Acid and Its Derivatives as Modulators of Metabolic Nuclear Receptors
Mohamed O. Radwan, Sultan Kadasah, Salha M. Aljubiri, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1465-1465
Open Access | Times Cited: 9
Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health
Sam Lockhart, Milan Mušo, Ilona Zvetkova, et al.
Nature Metabolism (2024) Vol. 6, Iss. 10, pp. 1922-1938
Open Access | Times Cited: 3
Improvement of Theaflavins on Glucose and Lipid Metabolism in Diabetes Mellitus
Shiyu Xu, Ying Chen, Yushun Gong
Foods (2024) Vol. 13, Iss. 11, pp. 1763-1763
Open Access | Times Cited: 2
Stearoyl-CoA desaturase-1: a potential therapeutic target for neurological disorders
Melanie Loix, Sam Vanherle, Marta Turri, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
In Silico Treatment: a computational framework for animal model selection and drug assessment
Sergio Picart‐Armada, Kolja Becker, Marc Kaestle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway
Sisi Lei, Weihang Peng, Lulu Wu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis
Karolien Buyl, Martine Vrints, Ruani Fernando, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175989-175989
Open Access | Times Cited: 3
A Novel Mutation in LXRα Uncovers a Role for Cholesterol Sensing in Limiting Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Alexis T. Clark, Lillian Russo-Savage, Luke A. Ashton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway
Neil Yang, J Chao, Kelly A Garton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Exploration of anti-atherosclerotic activity of 1,8-cineole through network pharmacology, molecular docking, and in vivo efficacy studies in high-fat-diet-induced atherosclerosis in hamsters
Shreya R. Savla, Lokesh Kumar Bhatt
Molecular Diversity (2024)
Closed Access
Future therapeutic perspectives in nonalcoholic fatty liver disease: a focus on nuclear receptors, a promising therapeutic target
Sorina Ionelia Stan, Viorel Biciușcă, Diana Clenciu, et al.
Medicine and Pharmacy Reports (2023) Vol. 97, Iss. 2, pp. 111-119
Open Access
Page 1

Scroll to top